amifostine anhydrous has been researched along with Abnormalities, Skin in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Xerostomia is a side effect of radiation therapy and, if not managed properly, can disrupt the patient's quality of life and lead to other health related issues." | 2.41 | Head and neck cancer: managing xerostomia and other treatment induced side effects. ( Gosselin, TK; Pavilonis, H, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gosselin, TK | 1 |
| Pavilonis, H | 1 |
1 review available for amifostine anhydrous and Abnormalities, Skin
| Article | Year |
|---|---|
Head and neck cancer: managing xerostomia and other treatment induced side effects.
Topics: Amifostine; Fatigue; Head and Neck Neoplasms; Humans; Pain; Pain Management; Skin Abnormalities; Tre | 2002 |